CL
AXSM icon

CSS LLC’s Axsome Therapeutics AXSM Stock Holding History

CSS LLC’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-27,900
Closed -$2.15M – 736
2022
Q4 		$2.15M Buy
27,900
+2,000
+8% +$120K 0.12% 164
2022
Q3 		$1.16M Sell
25,900
-15,800
-38% -$789K 0.05% 313
2022
Q2 		$1.6M Buy
41,700
+17,800
+74% +$563K 0.07% 331
2022
Q1 		$989K Sell
23,900
-2,300
-9% -$71.3K 0.04% 441
2021
Q4 		$990K Buy
26,200
+1,700
+7% +$62.5K 0.04% 433
2021
Q3 		$807K Buy
+24,500
New +$955K 0.03% 479
2021
Q2 		– Sell
-4,400
Closed -$249K – 1078
2021
Q1 		$249K Sell
4,400
-7,300
-62% -$514K 0.01% 718
2020
Q4 		$953K Buy
11,700
+200
+2% +$15K 0.04% 328
2020
Q3 		$820K Buy
11,500
+500
+5% +$39K 0.04% 334
2020
Q2 		$905K Sell
11,000
-3,300
-23% -$254K 0.05% 286
2020
Q1 		$842K Sell
14,300
-41,700
-74% -$3.4M 0.07% 229
2019
Q4 		$5.79M Buy
+56,000
New +$2.26M 0.32% 69

Other funds holding AXSM

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CSS LLC's AXSM Position: Q1 2023 in Review

CSS LLC sold out of Axsome Therapeutics (AXSM) in Q1 2023, closing a stake of 10,613 shares — an estimated $819K sold.

CSS LLC first reported a position in AXSM in Q4 2019 and held it in 10 quarters. The position peaked at $7.19M in Q4 2019. 196 funds tracked by Wall St. Rank hold AXSM as of Q1 2023.

  • CSS LLC reported no remaining Axsome Therapeutics position as of Q1 2023 after selling out during the quarter.
  • CSS LLC sold 10,613 Axsome Therapeutics shares in Q1 2023, an estimated $819K.
  • CSS LLC first reported a position in Axsome Therapeutics in Q4 2019 and held it in 10 quarters.
  • CSS LLC's Axsome Therapeutics position peaked at $7.19M in Q4 2019.
  • 196 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2023.

Based on CSS LLC's 13F filing for Q1 2023, filed 15 May 2023.